Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3

被引：3
|
作者：
Ferreira, Emanuel [1 ,2 ]
Oliveira, Nuno [1 ,2 ]
Marques, Maria [1 ,2 ]
Francisco, Luis [2 ,3 ]
Santos, Ana [1 ,2 ]
Carreira, Armando [1 ,2 ]
Campos, Mario [1 ,4 ]
机构：
[1] Ctr Hosp Coimbra, Serv Nefrol, Rua Buxo,Lote 17, P-3040792 Coimbra, Portugal
[2] Univ Coimbra, Hosp Geral, Rua Buxo,Lote 17, P-3040792 Coimbra, Portugal
[3] Ctr Hosp Coimbra, Serv Hematol, Coimbra, Portugal
[4] Univ Coimbra, Hosp Univ Coimbra, Coimbra, Portugal
来源：
NEFROLOGIA | 2016年 / 36卷 / 01期
关键词：
AHUS;
D O I：
10.1016/j.nefro.2015.07.007
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 75
页数：4
相关论文
共 50 条
  • [21] Mutations in atypical hemolytic uremic syndrome provide evidence for the role of calcium in complement factor I
    Java, Anuja
    Atkinson, John
    Hu, Zheng
    Pozzi, Nicola
    BLOOD, 2023, 142 (06) : 607 - 610
  • [22] Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome in Infants
    Ariceta, Gema
    Arrizabalaga, Beatriz
    Aguirre, Mireia
    Morteruel, Elvira
    Lopez-Trascasa, Margarita
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (05) : 707 - 710
  • [23] Success of eculizumab in the treatment of atypical hemolytic uremic syndrome
    Esra Baskin
    Kaan Gulleroglu
    Asli Kantar
    Umut Bayrakci
    Ozan Ozkaya
    Pediatric Nephrology, 2015, 30 : 783 - 789
  • [24] Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation
    Toyoda, Hidemi
    Wada, Hideo
    Miyata, Toshiyuki
    Amano, Keishiro
    Kihira, Kentaro
    Iwamoto, Shotaro
    Hirayama, Masahiro
    Komada, Yoshihiro
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (03) : E137 - E139
  • [25] Success of eculizumab in the treatment of atypical hemolytic uremic syndrome
    Baskin, Esra
    Gulleroglu, Kaan
    Kantar, Asli
    Bayrakci, Umut
    Ozkaya, Ozan
    PEDIATRIC NEPHROLOGY, 2015, 30 (05) : 783 - 789
  • [26] Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Pediatric and Adult Patients with or without Identified Genetic Complement Mutations or Complement Factor H Autoantibodies
    Cataland, Spero R.
    Feldkamp, Thorsten
    Bedrosian, Camille L.
    Kincaid, John
    Minetti, Enrico E.
    BLOOD, 2014, 124 (21)
  • [27] Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome
    Cugno, M.
    Gualtierotti, R.
    Possenti, I.
    Testa, S.
    Tel, F.
    Griffini, S.
    Grovetti, E.
    Tedeschi, S.
    Salardi, S.
    Cresseri, D.
    Messa, P.
    Ardissino, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (09) : 1440 - 1448
  • [28] Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Patients with or without Identified Genetic Complement Mutations or Complement Factor H Auto-Antibodies
    Al-Akash, Samhar I.
    Goodship, Timothy H. J.
    Smith, Richard J. H.
    Legendre, Christophe M.
    Licht, Christoph
    Muus, Petra
    Bedrosian, Camille L.
    Fremeaux-Bacchi, Veronique
    Loirat, Chantal
    BLOOD, 2012, 120 (21)
  • [29] Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
    Legendre, C. M.
    Licht, C.
    Muus, P.
    Greenbaum, L. A.
    Babu, S.
    Bedrosian, C.
    Bingham, C.
    Cohen, D. J.
    Delmas, Y.
    Douglas, K.
    Eitner, F.
    Feldkamp, T.
    Fouque, D.
    Furman, R. R.
    Gaber, O.
    Herthelius, M.
    Hourmant, M.
    Karpman, D.
    Lebranchu, Y.
    Mariat, C.
    Menne, J.
    Moulin, B.
    Nuernberger, J.
    Ogawa, M.
    Remuzzi, G.
    Richard, T.
    Sberro-Soussan, R.
    Severino, B.
    Sheerin, N. S.
    Trivelli, A.
    Zimmerhackl, L. B.
    Goodship, T.
    Loirat, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23): : 2169 - 2181
  • [30] A case of atypical hemolytic uremic syndrome with kidney biopsy consistent with C3 nephropathy treated with eculizumab
    Vivarelli, Marina
    Diomedi-Camassei, Francesca
    Sperli, Domenico
    Emma, Francesco
    MOLECULAR IMMUNOLOGY, 2015, 67 (01) : 192 - 193
12345